BELLE Capital

TO THE MARKET specializes in the ethical manufacturing and sourcing of apparel, accessories, and home goods. Established in 2016 and based in the United States, the company collaborates with artisan groups and suppliers globally to provide sustainable solutions. Its services encompass design, production, compliance, sourcing, logistics, and reporting, catering to a diverse clientele, including Fortune 500 companies, brands, and retailers. By focusing on transparency, sustainability, and authenticity, TO THE MARKET aims to create products that resonate with a new generation of consumers, while promoting a supply chain that empowers communities and protects the environment.

TO THE MARKET specializes in the ethical manufacturing and sourcing of apparel, accessories, and home goods. Established in 2016 and based in the United States, the company collaborates with artisan groups and suppliers globally to provide sustainable solutions. Its services encompass design, production, compliance, sourcing, logistics, and reporting, catering to a diverse clientele, including Fortune 500 companies, brands, and retailers. By focusing on transparency, sustainability, and authenticity, TO THE MARKET aims to create products that resonate with a new generation of consumers, while promoting a supply chain that empowers communities and protects the environment.

Ocuphire Pharma is a clinical-stage biopharmaceutical company committed to the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders. We are currently focused on providing a novel once-daily eye drop treatment option, Nyxol®, to treat multiple front-of-the-eye disorders, including night vision disturbances, glaucoma, pharmacologically-induced mydriasis, and presbyopia. Nyxol eye drops are an investigational 505(b)(2) drug candidate in late-stage clinical development with over a decade of safety and efficacy data from Phase 1 and 2 trials. Part of our strategy is to explore opportunities to acquire additional ophthalmic assets for both the front and the back of the eyes, and to seek strategic partners for global commercialization.

Vyv, formerly known as Vital Vio, Inc., designs and manufactures advanced lighting systems branded as VioSafe, focusing on antibacterial solutions. The company produces a range of products, including under cabinet lights, replacement bulbs, and various LED fixtures specifically designed to combat germs and enhance infection control in diverse settings. Its products are utilized in commercial environments such as hospitals, veterinary clinics, laboratories, schools, and food preparation facilities, among others. Vyv aims to protect people and spaces from harmful microorganisms by integrating antimicrobial properties into its lighting solutions. Founded in 2012 and headquartered in Troy, New York, the company has established partnerships with notable organizations, including Duke University and UCLA Health, and serves various sectors, including healthcare, food processing, and commercial industries.

Joylux, Inc. is a health and wellness company based in Seattle, Washington, that focuses on women's health and wellness. Founded in 2013, the company develops LED-focused medical devices designed to address pelvic-floor issues. Its primary product is an at-home device that provides pelvic-floor toning and vaginal rejuvenation. Joylux is dedicated to delivering noninvasive, effective, and affordable solutions to enhance women's intimate health and overall quality of life.

Digsite, Inc. develops a platform for online insight communities that improve on outdated online focus group technology. Its platform enables moderators to start public or private discussions, upload images and videos, and use survey and mark-up tools; and participants to add their own comments and discussions. The company also provides SmartReporting, which enables marketers and brand managers to bring qualitative research results to life. Digsite, Inc. was founded in 2014 and is based in Madison, Wisconsin.

Cardialen, Inc., a medical device company that develops a therapy system that detects and treats atrial fibrillation, rapid ventricular tachycardia, and ventricular fibrillation. It offers an implantable device to restore normal heart rhythm and may reduce the potential for high-energy defibrillation shocks. The company was incorporated in 2008 and is based in Minneapolis, Minnesota.

Current Motor Company is based in Ann Arbor, Michigan, and specializes in the development and manufacture of electric motor scooters aimed at urban commuters. The company produces all-electric maxi-scooters that are designed to be fast, fun, and affordable, offering zero-emission transportation solutions. These maxi-scooters can reach speeds of up to 70 MPH and have a range of up to 50 miles, charging conveniently from a standard 110V outlet in approximately five hours. Current Motor sells and services its products through a network of dealers and has formed a strategic partnership with Dakkota Integrated Systems. The company is supported by various investors, including BELLE Capital and the State of Michigan.